Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, Wanbury has informed that the Trading Window for dealing in securities of the Company shall remain closed for the Designated Persons Directors, identified Employees, KMPs, Promoter and Promoter Group of the Company and its subsidiaries including Immediate Relatives of the Designated Persons of the Company and its subsidiaries and for the Connected Persons commencing from 1st January, 2023 till 48 hours after the declaration of Un-audited Financial Results (UFR) of the Company for the quarter and nine months ended 31st December, 2022. The date of the Board Meeting of the Company for declaration of Un-audited Financial Results for the quarter and nine months ended 31st December, 2022 will be intimated in due course of time.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1521.95 |
Dr. Reddys Lab | 6279.95 |
Cipla | 1407.55 |
Zydus Lifesciences | 963.50 |
Lupin | 1640.30 |
View more.. |